61 related articles for article (PubMed ID: 38689213)
41. External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy.
Owari T; Miyake M; Nakai Y; Tanaka N; Itami Y; Hirao S; Momose H; Nakagawa Y; Iida K; Maesaka F; Shimizu T; Iemura Y; Matsumoto Y; Kuwada M; Otani T; Otsuka K; Okajima E; Hosokawa Y; Okamura R; Fujimoto K
J Bone Oncol; 2021 Feb; 26():100344. PubMed ID: 33384916
[TBL] [Abstract][Full Text] [Related]
42. Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma.
Cheaib JG; Claus LE; Patel HD; Kates MR; Matoso A; Hahn NM; Bivalacqua TJ; Hoffman-Censits JH; Pierorazio PM
Urol Oncol; 2021 Jan; 39(1):74.e9-74.e16. PubMed ID: 33071108
[TBL] [Abstract][Full Text] [Related]
43. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J
Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146
[TBL] [Abstract][Full Text] [Related]
44. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis.
Wu J; Zhang H; Li L; Hu M; Chen L; Xu B; Song Q
Cancer Commun (Lond); 2020 Jul; 40(7):301-312. PubMed ID: 32558385
[TBL] [Abstract][Full Text] [Related]
45. Novel prognostic nomograms for female patients with breast cancer and bone metastasis at presentation.
Wang Z; Cheng Y; Chen S; Shao H; Chen X; Wang Z; Wang Y; Zhou H; Chen T; Lin N; Ye Z
Ann Transl Med; 2020 Mar; 8(5):197. PubMed ID: 32309344
[TBL] [Abstract][Full Text] [Related]
46. Bone density and pain response following intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases - secondary results of a randomized trial.
Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
Radiat Oncol; 2018 Oct; 13(1):212. PubMed ID: 30376859
[TBL] [Abstract][Full Text] [Related]
47. Clinical Features and Risk Factors of Skeletal-Related Events in Genitourinary Cancer Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma.
Owari T; Miyake M; Nakai Y; Morizawa Y; Itami Y; Hori S; Anai S; Tanaka N; Fujimoto K
Oncology; 2018; 95(3):170-178. PubMed ID: 29874673
[TBL] [Abstract][Full Text] [Related]
48. Upper tract urothelial carcinoma: a different disease entity in terms of management.
Leow JJ; Chong KT; Chang SL; Bellmunt J
ESMO Open; 2016; 1(6):e000126. PubMed ID: 28848663
[TBL] [Abstract][Full Text] [Related]
49. Epidemiology of urothelial carcinoma.
Miyazaki J; Nishiyama H
Int J Urol; 2017 Oct; 24(10):730-734. PubMed ID: 28543959
[TBL] [Abstract][Full Text] [Related]
50. Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.
Tsuda Y; Nakagawa T; Shinoda Y; Kanatani A; Kawai T; Taguchi S; Yamada Y; Sawada R; Kume H; Homma Y; Tanaka S; Kawano H
Int J Clin Oncol; 2017 Jun; 22(3):548-553. PubMed ID: 28044212
[TBL] [Abstract][Full Text] [Related]
51. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.
Liang W; He J; Shen Y; Shen J; He Q; Zhang J; Jiang G; Wang Q; Liu L; Gao S; Liu D; Wang Z; Zhu Z; Ng CS; Liu CC; Petersen RH; Rocco G; D'Amico T; Brunelli A; Chen H; Zhi X; Liu B; Yang Y; Chen W; Zhou Q; He J
J Clin Oncol; 2017 Apr; 35(11):1162-1170. PubMed ID: 28029318
[TBL] [Abstract][Full Text] [Related]
52. Predicting Survival After Irradiation of Metastases from Transitional Carcinoma of the Bladder.
Manig L; Käsmann L; Janssen S; Rades D
Anticancer Res; 2016 Dec; 36(12):6663-6665. PubMed ID: 27919999
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma.
Seisen T; Jindal T; Karabon P; Sood A; Bellmunt J; Rouprêt M; Leow JJ; Vetterlein MW; Sun M; Alanee S; Choueiri TK; Trinh QD; Menon M; Abdollah F
Eur Urol; 2017 May; 71(5):714-718. PubMed ID: 27912971
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma.
Huang YC; Chang YH; Chiu KH; Shindel AW; Lai CH
Sci Rep; 2016 Dec; 6():38175. PubMed ID: 27910890
[TBL] [Abstract][Full Text] [Related]
55. A contemporary review of management and prognostic factors of upper tract urothelial carcinoma.
Leow JJ; Orsola A; Chang SL; Bellmunt J
Cancer Treat Rev; 2015 Apr; 41(4):310-9. PubMed ID: 25736461
[TBL] [Abstract][Full Text] [Related]
56. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771
[TBL] [Abstract][Full Text] [Related]
57. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma.
Galsky MD; Chen GJ; Oh WK; Bellmunt J; Roth BJ; Petrioli R; Dogliotti L; Dreicer R; Sonpavde G
Ann Oncol; 2012 Feb; 23(2):406-10. PubMed ID: 21543626
[TBL] [Abstract][Full Text] [Related]
58. A prospective natural-history study of coronary atherosclerosis.
Stone GW; Maehara A; Lansky AJ; de Bruyne B; Cristea E; Mintz GS; Mehran R; McPherson J; Farhat N; Marso SP; Parise H; Templin B; White R; Zhang Z; Serruys PW;
N Engl J Med; 2011 Jan; 364(3):226-35. PubMed ID: 21247313
[TBL] [Abstract][Full Text] [Related]
59. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005.
Raman JD; Messer J; Sielatycki JA; Hollenbeak CS
BJU Int; 2011 Apr; 107(7):1059-64. PubMed ID: 20825397
[TBL] [Abstract][Full Text] [Related]
60. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.
Kaag MG; O'Malley RL; O'Malley P; Godoy G; Chen M; Smaldone MC; Hrebinko RL; Raman JD; Bochner B; Dalbagni G; Stifelman MD; Taneja SS; Huang WC
Eur Urol; 2010 Oct; 58(4):581-7. PubMed ID: 20619530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
